Clinical and angiographical characteristics of acetylcholine-induced spasm: Relationship to dose of intracoronary injection of acetylcholine

Coronary Artery Disease

Volumn 13, Issue 4, 2002, Pages 231-236

  Sueda, Shozo ^a   Kohno, Hiroaki ^a   Fukuda, Hiroshi ^a   Inoue, Katsuji ^a   Suzuki, Jun ^a   Watanabe, Kouki ^a   Ochi, Takaaki ^a   Uraoka, Tadao ^a  

^a Saiseikai Saijo Hospital   (Japan)

Author keywords

Acetycholine; Dose; Spasm configuration; Variant angina

Indexed keywords

ACETYLCHOLINE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY; CORONARY ARTERY SPASM; DIAGNOSTIC TEST; DOSE RESPONSE; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; INTRACORONARY INFUSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; THORAX PAIN; VARIANT ANGINA PECTORIS;

ACETYLCHOLINE; ANGINA PECTORIS, VARIANT; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 0036619808     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200206000-00005     Document Type: Article

References (18)

1. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986; 74:955-963.
2. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H, et al. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988; 12:883-888.
3. Murakami T, Mizuno S, Ohsato K, Moriuchi I, Arai Y, Nio Y, et al. Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus. Am J Cardiol 1999; 84:92-94.
4. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315:1046-1051.
5. Newman CM, Maseri A, Hackett DR, El-Tamimi HM, Davies GJ. Response of angiographically normal and atherosclerotic left anterior descending coronary arteries to acetylcholine. Am J Cardiol 1990; 66:1070-1076.
6. Sueda S, Ochi N, Kawada H, Matsuda S, Hayashi Y, Tsuruoka T, et al. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol 1999; 83:1186-1190.
7. Sueda S, Saeki H, Otani T, Mineoi K, Kondou T, Yano K, et al. Major complications during spasm provocation tests with an intracoronary injection of acetylcholine. Am J Cardiol 2000; 85:391-394.
8. Sueda S, Fukuda H, Watanabe K, Ochi N, Kawada H, Hayashi Y, et al. Clinical characteristics and possible mechanism of paroxysmal atrial fibrillation induced by intracoronary injection of acetylcholine. Am J Cardiol 2001; 88:570-573.
9. Sueda S, Fukuda H, Watanabe K, Ochi N, Kawada H, Hayashi Y, et al. Usefulness of accelerated exercise following mild hyperventilation for the induction of coronary artery spasm: comparison with an acetylcholine test. Chest 2001; 119:155-162.
10. Sueda S, Ochi T, Yano K, Mineoi K, Kondou T, Ochi N, et al. New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine. Jpn Circ J 2000; 64:559-565.
11. Sueda S, Suzuki J, Watanabe K, Ochi N, Hayashi Y, Kawada H, et al. New non-invasive protocol for detection of coronary spastic angina with significant organic stenosis. Coron Artery Dis 2001; 12:295-303.
12. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LSG, et al. A reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease, council on cardiovascular surgery, American Heart Association. Circulation 1975; 51:5-40.
13. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 8:373-376.
14. Nobuyoshi M, Abe M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, et al. Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. Am Heart J 1992; 124:32-38.
15. Okumura K, Yasue H, Matsuyama K, Ogawa H, Kugiyama K, Ishizuka H, et al. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. J Am Coll Cardiol 1996; 27:45-52.
16. Miyao Y, Kugiyama K, Kawano H, Motoyama T, Ogawa H, Yoshimura M, et al. Diffuse intimal tickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 2000; 36:432-437.
17. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998; 103:65-69.
18. 786C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99:2864-2870.